Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1990
09/12/1990EP0386611A2 Amino acid derivatives
09/12/1990EP0386563A1 Antisense-oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (Tat) of HIV-I, and their use
09/12/1990EP0386275A2 Anti-idiotype intermediate method of making binding site mimics
09/12/1990EP0386240A1 Novel polypeptide compounds
09/12/1990EP0386140A1 Factors associated with essential hypertension
09/12/1990EP0386109A1 Acceleration of bone formation with gm-csf
09/12/1990EP0386076A1 Phosphoryled derivatives of cardiodilatine/anf peptides.
09/12/1990EP0386059A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition
09/12/1990EP0386045A1 Derivatives of type a and type b synergimycins.
09/12/1990EP0386002A1 Gene transfer for drug resistance
09/12/1990EP0302065A4 Pharmaceutical compositions
09/11/1990WO1990010651A1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient
09/11/1990WO1990010462A1 Combination therapy for treatment of estrogen sensitive diseases
09/11/1990US4956504 Immunomodulators, antibiotics
09/11/1990US4956455 Bovine fibroblast growth factor
09/11/1990US4956453 Anti-human ovarian cancer immunotoxins and methods of use thereof
09/11/1990US4956364 6-alkyl-5-oxo-3-thiomorpholinylcarbonylhistidylprolinamide
09/11/1990US4956355 Ketosteroids for viral infections
09/11/1990US4956344 Pyroglutamylhistidylglycine anticarcinogenic agents
09/11/1990US4956343 Control of insects by Roseotoxin B
09/11/1990US4956281 DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
09/11/1990CA2048993A1 Molecular cloning of genomic and cdna sequences encoding cellular receptors for poliovirus
09/11/1990CA1273870A1 Composition with cosmetic or pharmaceutical use containing niosomes and at least one watersoluble polyamide and process for the preparation of the said composition
09/10/1990WO1990010652A1 Method of treating viral infections using lfa-1
09/10/1990WO1990010646A1 Leukocyte adhesion receptors
09/10/1990CA2050329A1 Method of treating viral infections using lfa-1
09/10/1990CA2050326A1 Leukocyte adhesion receptors
09/10/1990CA2011877A1 Cdna coding for placental protein 9 (pp9), the isolation and use thereof
09/09/1990WO1990010645A1 Glycosylated insulins
09/09/1990CA2049937A1 Glycosylated insulins
09/08/1990WO1990010454A1 Metabolic effects of leukaemia inhibitory factor on bone
09/08/1990WO1990010448A2 Covalent conjugates of lipid and oligonucleotide
09/08/1990CA2049028A1 Covalent conjugates of lipid and oligonucleotide
09/08/1990CA2048673A1 Metabolic effects of leukaemia inhibitory factor on bone
09/07/1990WO1990010649A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression
09/07/1990WO1990010070A1 Il-2 analogs containing n-linked glycosylation sites
09/07/1990WO1990010068A1 Il-1 biological activity inhibitors
09/07/1990WO1990010067A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition
09/07/1990WO1990010018A1 Bone collagen matrix for implants
09/07/1990WO1990010016A1 Class i mhc modulation of surface receptor activity
09/07/1990WO1990010013A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
09/07/1990WO1990009806A2 Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses
09/07/1990WO1990009804A1 Genetically engineered immunoglobulins
09/07/1990WO1990009802A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
09/07/1990WO1990009800A1 Modified forms of reproductive hormones
09/07/1990WO1990009799A1 GnRH ANALOGS FOR DESTROYING GONADOTROPHS
09/07/1990WO1990009793A1 Method of treating gastrointestinal malignancies
09/07/1990WO1990009782A1 Liposome gel composition and method
09/07/1990WO1990009737A1 Human elastase inhibitor
09/07/1990WO1990007862A3 Generation and selection of novel dna-binding proteins and polypeptides
09/06/1990CA2011365A1 Diluent formulation for daptomycin
09/06/1990CA2010531A1 Amino acid derivatives
09/05/1990EP0385936A1 Peptide lactone and derivatives thereof, process for their production and means for carrying out the process
09/05/1990EP0385909A2 A kit or composition for the prevention or treatment of HIV-1 infections
09/05/1990EP0385712A2 A peptide for use in the manufacture of a composition for prevention or treatment of a condition susceptible to treatment with a platelet aggregation inhibition agent
09/05/1990EP0385659A2 Multifunctional polypeptides and method for the preparation thereof
09/05/1990EP0385593A1 Phosphorus containing renin inhibitors
09/05/1990EP0385558A2 Materials and methods for genome walking
09/05/1990EP0385476A1 Physiologically active polypeptide and DNA
09/05/1990EP0385467A1 Muramyl peptide derivatives and immunoregulating compositions containing them
09/05/1990EP0385385A2 Human monocyte-machrophage-CSF preparations
09/05/1990EP0385373A2 Treatment of autoimmune diseases
09/05/1990EP0385308A1 Production of a peptide from human cancer cells
09/05/1990EP0385279A2 Bioactive agents, compositions and materials comprising said bioactive agents
09/05/1990EP0385118A2 Use of compounds containing or binding sialic acid to neutralize bacterial toxins
09/05/1990EP0385060A2 Purified ciliary neurotrophic factor
09/05/1990EP0346501A4 Pharmaceutical preparation for treating immunodeficiency conditions
09/05/1990EP0246439B1 Sterile plasma substitute
09/05/1990CN1045184A Immunodiagnostic method
09/05/1990CN1045035A Medicines for passive immunization therapy and prevention people immunolodeficiency virus infection and process for preparing them
09/04/1990US4954638 Leukotriene by amides and hydrazides
09/04/1990US4954625 Piperidine derivatives, their production and use
09/04/1990US4954617 Diagnosis, antitumor, immunology
09/04/1990US4954483 Carboxylic acid ester derivatives or deglucoteicoplanin
09/04/1990US4954482 New glycopeptide antibiotic
09/04/1990US4954449 Human monoclonal antibody reactive with polyribosylribitol phosphate
09/04/1990US4954437 Cell encoding recombinant human erythropoietin
09/04/1990US4954358 Multiplication inhibitor for Bacillus cereus
09/04/1990US4954342 Hypercalocemic agents
09/04/1990US4954340 Method for activating hemocytes of bivalves for pearl production
09/04/1990CA1273750A1 Analogues of polypeptides hypocalcemia-inducing compounds which spare the body's calcium preparation, use as a drug and compositions containing such analogues
09/04/1990CA1273591A1 Production of protein
09/03/1990CA2011327A1 Renin-inhibitory di-, tri-, and tetrapeptides
09/03/1990CA2011299A1 Aids therapy
09/03/1990CA2011275A1 Muramyl peptide derivatives and immunoregulating compositions containing them
09/02/1990WO1990010228A1 Matrix metalloproteinase peptides: role in diagnosis and therapy
09/02/1990WO1990009739A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
09/02/1990CA2008454A1 Linear analog of biologically active mammalian grp or amphibian bombesin
08/1990
08/31/1990CA2011095A1 Il-2 analogs containing n-linked glycosylation sites
08/31/1990CA2010593A1 Production of novel polypeptide
08/30/1990DE3905723A1 Use of tPA for the prophylaxis and/or therapy of complications of pregnancy
08/29/1990WO1990009805A1 Human monoclonal antibodies to human immunodeficiency virus
08/29/1990EP0384752A2 Milled proteins
08/29/1990EP0384731A2 Osteogenic growth polypeptides identified from regenerating bone marrow
08/29/1990EP0384559A1 Use of trypstatin for the manufacture of a medicament in the treatment of AIDS
08/29/1990EP0384494A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
08/29/1990EP0384380A2 Novel peptide derivatives and their pharmaceutical use
08/29/1990EP0384362A2 Glycinderivatives
08/29/1990EP0384302A2 Use of ubenimex in the manufacture of a medicament for treating myelodysplastic syndrome
08/29/1990EP0384144A1 Pharmaceutical composition for diseases caused by vasoconstriction